David M Faleck

15PUBLICATIONS
74CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 12, 2024
Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis.

Joan Shang, Diane Marie Del Valle, Graham J Britton

|Jul 20, 2024
Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors.

Patrick Tiongco Magahis, Tara Corso, Pamela Livingstone

|Dec 18, 2023
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.

Arielle Elkrief, Nicholas R Waters, Natalie Smith

|Nov 25, 2023
IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events.

Stephanie L Gu, Tara Maier, Andrea P Moy

|Oct 29, 2023
Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors.

Patrick T Magahis, Steven B Maron, Darren Cowzer

|Sep 18, 2023
Prevalence of Enteric Infections in Patients on Immune Checkpoint Inhibitors and Impact on Management and Outcomes.

Patrick T Magahis, Deepika Satish, Ngolela Esther Babady

Pageof 3